本页面由Tiger Trade Technology Pte. Ltd.提供服务

Esperion Therapeutics Inc.

3.18
0.0000
成交量:- -
成交额:- -
市值:8.17亿
市盈率:-94.97
高:3.18
开:3.18
低:3.18
收:3.18
52周最高:4.18
52周最低:1.10
股本:2.57亿
流通股本:2.42亿
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.0335
每股收益(LYR):-0.1091
净资产收益率:97.76%
总资产收益率:12.04%
市净率:-2.65
市盈率(LYR):-29.14

数据加载中...

2026/07/13

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/07/13

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2026/07/13

重要事件披露

Form 8-K - Current report
2026/07/08

重要事件披露

Form 8-K - Current report
2026/06/18

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/22

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/03

重要事件披露

Form 8-K - Current report
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]